Evidence map›Paper›PMID 32494607›Full record

ArticleScience advances2020

Under oil open-channel microfluidics empowered by exclusive liquid repellency.

Chao Li, Zachary Hite, Jay W Warrick, Jiayi Li, Stephanie H Geller, Victoria G Trantow, Megan N McClean, David J Beebe

Abstract read
In one paragraph

Article in Science advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Article
  3. In Vitro Monitoring of Babesia microti Infection Dynamics in Whole Blood Microenvironments.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Co-zorbs: Motile, multispecies biofilms aid transport of diverse bacterial species.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chao LiCarbone Cancer Center, University of Wisconsin-Madison, Madison, WI 53705, USA.ORCID 0000-0002-1126-0655
Zachary HiteDepartment of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI 53705, USA.ORCID 0000-0003-2645-9402
Jay W WarrickDepartment of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI 53705, USA.ORCID 0000-0002-4801-8897
Jiayi LiDepartment of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI 53705, USA.
Stephanie H GellerDepartment of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI 53705, USA.
Victoria G TrantowDepartment of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI 53705, USA.
Megan N McCleanDepartment of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI 53705, USA.ORCID 0000-0002-1141-4802
David J BeebeCarbone Cancer Center, University of Wisconsin-Madison, Madison, WI 53705, USA.ORCID 0000-0002-0415-9006

Funding

An automated high-throughput tissue model for screening metastatic effectorsR01CA186134 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI BEEBE, DAVID J · 2015 to 2019
$3.1M
[PQC-3] A Metabolic Pathway Activation Marker for Prostate Cancer PrognosisR01CA185251 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI BASU, HIRAK S., BEEBE, DAVID J · 2014 to 2017
$2.9M
Understanding cell migration through microscale in vitro modelsR01EB010039 · NIBIB · UNIVERSITY OF WISCONSIN-MADISON · PI BEEBE, DAVID J, HUTTENLOCHER, ANNA · 2011 to 2014
$1.7M
VERSA: An Integrated, Multi-Endpoint Platform for Circulating Tumor Cell AnalysisR01CA181648 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI BERRY, SCOTT M, LANG, JOSHUA MICHAEL · 2014 to 2018
$1.6M
An optogenetic toolkit for spatiotemporal control of gene expression in Candida albicansR21AI135166 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI ANDES, DAVID R, MCCLEAN, MEGAN N · 2019 to 2020
$427k
NCI NIH HHS R01 CA181648NCI NIH HHS R01 CA185251NCI NIH HHS R01 CA186134NIAID NIH HHS R21 AI135166NIBIB NIH HHS R01 EB010039
6 · The paper itself

Abstract

Recently, the functionality of under oil open microfluidics was expanded from droplet-based operations to include lateral flow in under oil aqueous channels. However, the resolution of the under oil fluidic channels reported so far is still far from comparable with that of closed-channel microfluidics (millimeters versus micrometers). Here, enabled by exclusive liquid repellency and an under oil sweep technique, open microchannels can now be prepared under oil (rather than in air), which shrinks the channel dimensions up to three orders of magnitude compared to previously reported techniques. Spatial trapping of different cellular samples and advanced control of mass transport (i.e., enhanced upper limit of flow rate, steady flow with passive pumping, and reversible fluidic valves) were achieved with open-channel designs. We apply these functional advances to enable dynamic measurements of dispersion from a pathogenic fungal biofilm. The ensemble of added capabilities reshapes the potential application space for open microfluidics.

Identifiers

PMID32494607
PMCPMC7164933

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.